Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Carl Gordon Insider Profile
39 Followers
Carl Gordon, Director at Intellia Therapeutics, holds ― shares in Intellia Therapeutics (Ticker: NTLA), holds 0.00 shares in Kinnate Biopharma (Ticker: KNTE), holds 0.00 shares in Theseus Pharmaceuticals (Ticker: THRX). Most recently, Carl Gordon ― shares of Intellia Therapeutics on ― for an estimated value of ―.
Profitable Transactions
9 out of 24 Profitable Transactions
Average Return
-2.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Carl Gordon holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 13, 2020 - Apr 13, 2021
Return:+175.70%
The most profitable trade made by Carl Gordon
Carl Gordon's Trading History
Intellia Therapeutics
―
Director
―
―
X4 Pharmaceuticals
Nov 20, 2017
Director
Uninformative Buy
―
$2.35M
Armo Biosciences Inc
Jun 22, 2018
―
Uninformative Sell
205.95M
$0.00
Alector
Feb 11, 2019
Director, Ten Percent Owner
Uninformative Buy
―
$1.03M
Turning Point Therapeutics
Apr 24, 2019
―
Uninformative Buy
―
$154.11M
Prevail Therapeutics
Jun 26, 2019
―
Uninformative Buy
―
$317.92M
Keros Therapeutics
Apr 13, 2020
Director
Uninformative Buy
―
$65.26M
Oric Pharmaceuticals
Mar 31, 2021
Director, Ten Percent Owner
Uninformative Sell
2.43M
$20.33M
Adicet Bio
Jan 26, 2024
Director, Ten Percent Owner
Informative Buy
7.50M
$5.71M
Kinnate Biopharma
Apr 05, 2024
―
Uninformative Sell
―
$0.00
Terns Pharmaceuticals
Dec 28, 2022
Director, Ten Percent Owner
Informative Buy
1000.00K
$34.74M
Disc Medicine
―
Director, Ten Percent Owner
―
―
Theseus Pharmaceuticals
Feb 14, 2024
―
Uninformative Sell
―
$0.00
Compass Therapeutics
Nov 10, 2022
Director, Ten Percent Owner
Informative Buy
1.29M
$27.62M
ArriVent BioPharma, Inc.
Jan 31, 2024
Director, Ten Percent Owner
Uninformative Buy
―
$23.46M
Pacira Pharmaceuticals
Feb 10, 2011
Director
Informative Buy
13.33M
$74.26M
ACADIA Pharmaceuticals
―
Director
―
$23.47M
Acceleron Pharma
Sep 18, 2013
―
Uninformative Buy
―
$1.43M
Amarin
Sep 05, 2012
Director
Uninformative Sell
3.37M
$4.90K
BioCryst
―
Director
―
$0.00
Complete Genomics
―
―
―
―
List of latest transactions for each holding click on a transaction to see Carl Gordon's performance on stock
You May Also Like
Carl Gordon insider profile FAQ
What is the percentage of profitable transactions made by Carl Gordon?
The percentage of profitable transactions made by Carl Gordon is 38%.
What is the average return per transaction made by Carl Gordon?
The average return per transaction made by Carl Gordon is -2.30%.
What stocks does Carl Gordon hold?
Carl Gordon holds: NTLA, XFOR, ARMO, ALEC, TPTX, PRVL, KROS, ORIC, ACET, KNTE, TERN, IRON, THRX, CMPX, AVBP, PCRX, ACAD, XLRN, AMRN, BCRX, ~GNOM stocks.
What was Carl Gordon’s latest transaction?
Carl Gordon latest transaction was an Uninformative Buy of ―.
What was Carl Gordon's most profitable transaction?
Carl Gordon’s most profitable transaction was an Informative Buy of KROS stock on April 13, 2020. The return on the trade was 175.70%.
What is Carl Gordon's role in Intellia Therapeutics?
Carl Gordon's role in Intellia Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.